Specific drug interaction studies have not been conducted.
OVERDOSAGE
Clinical consequences of overdose with OMNISCAN have not been reported. The minimum lethal dose of intravenously administered OMNISCAN in rats and mice is greater than 20 mmol/kg (200 times the recommended human dose of 0.1 mmol/kg; 67 times the cumulative 0.3 mmol/kg dose). OMNISCAN is dialyzable.
CONTRAINDICATIONS
OMNISCAN is contraindicated in patients with:
chronic, severe kidney disease (glomerular filtration rate, GFR < 30 mL/min/1.73m2), or